Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma
Kshama Gupta(Desh Bhagat Ayurvedic College and Hospital), Sunil Krishnan(Smith Family)
Cited by 13
Related Papers
Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177
|Journal of Clinical Oncology|2008|275
Radiation-Induced Alterations in the Recurrent Glioblastoma Microenvironment: Therapeutic Implications
|Frontiers in Oncology|2018|93
An ERK5-NRF2 Axis Mediates Senescence-Associated Stemness and Atherosclerosis
|Circulation Research|2023|39
Immunomodulatory Effects of Gold Nanoparticles: Impacts on Immune Cells and Mechanisms of Action
|Nanomaterials|2025|15
Premature senescence and cardiovascular disease following cancer treatments: mechanistic insights
|Frontiers in Cardiovascular Medicine|2023|9